The Clinical Role of Preoperative Serum CA19-9 and Carcinoembryonic Antigen (CEA) Levels in Evaluating the Resectability of Advanced Gallbladder Cancer

Wencong Ma; Wei Li; Jinghan Wang; Rui Wu; Chen Liu; Feiling Feng; Xiaoqing Jiang

doi:10.12659/MSM.925017

20 September 2020 : Clinical Research

The Clinical Role of Preoperative Serum CA19-9 and Carcinoembryonic Antigen (CEA) Levels in Evaluating the Resectability of Advanced Gallbladder Cancer

Wencong Ma^1BCF, Wei Li^1DE, Jinghan Wang^1DF, Rui Wu^1BC, Chen Liu^1D, Feiling Feng^1AF*, Xiaoqing Jiang^1AEF

DOI: 10.12659/MSM.925017

Med Sci Monit 2020; 26:e925017

Authors information Article notes Copyright and License information

Related articles Order reprints Share article Share by email

View HTML version

Figure 1 ROC curves for preoperative serum CEA, total bilirubin, CA19-9, and adjusted CA19-9 levels in the determination of the resectability of gallbladder cancer.

Back to the Article

The Clinical Role of Preoperative Serum CA19-9 and Carcinoembryonic Antigen (CEA) Levels in Evaluating the Resectability of Advanced Gallbladder Cancer

Your Privacy